Cristiane Alves Villela Nogueira
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências da Saúde
Unidade:
Faculdade de Medicina
Departamento:
Departamento de Clínica Médica/FM
Formação:
-
Liver Center - Beth Israel Deaconess Medical Center
| Pós-Doutorado | 2008 - 2009
-
Universidade Federal do Rio de Janeiro
Medicina (Doenças Infecciosas e Parasitárias) | Doutorado | 1998 - 2000
-
Universidade Federal do Rio de Janeiro
Clínica Médica | Mestrado | 1988 - 1992
-
Universidade Federal do Rio de Janeiro
| Especialização - Residência medica | 1986 - 1988
-
Universidade Federal do Rio de Janeiro
Medicina | Graduação | 1980 - 1985
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
(65.22% artigos com DOI)
| Titulo | DOI | Ano |
|---|---|---|
| Impact of |
10.1111/liv.15845 | 2024 |
| Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis? | 10.1016/j.aohep.2024.101477. | 2024 |
| Body weight variability and the risk of liver¿related outcomes in type 2 diabetes and steatotic liver disease: a cohort study | 10.1002/oby.24035 | 2024 |
| A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score | 10.1097/meg.0000000000002744 | 2024 |
| Choosing Wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: a position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver | 10.1016/j.aohep.2022.100764 | 2023 |
| Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis | 10.3748/wjg.v29.i2.343 | 2023 |
| Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis | 10.1007/s10620-022-07654-x | 2023 |
| Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography | 10.1097/MEG.0000000000002507 | 2023 |
| O-36 UTILITY OF DRIED BLOOD SAMPLES FOR HEPATITIS C VIRUS GENOTYPING AMONG HCV/HIV-COINFECTED INDIVIDUALS | 10.1016/j.aohep.2023.101043 | 2023 |
| Acceptability and usability of oral fluid |
10.1111/jvh.13876 | 2023 |
| Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial | 10.1016/j.clnesp.2023.06.027 | 2023 |
| Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic | 10.20945/2359-4292-2023-0123 | 2023 |
| Patients with uncertain advanced fibrosis and cirrhosis diagnosis by Agile3+ and Agile4 scores cannot be excluded in validation studies. | 10.1111/hepr.13996 | 2023 |
| Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease | 10.1007/s10620-023-08214-7 | 2023 |
| Relationship of ferritin and hepcidin with disease severity in non¿alcoholic fatty liver disease patients with type 2 diabetes mellitus | 10.1111/liv.15747 | 2023 |
| Frequency distribution of HCV resistance-associated variants in infected patients treated with direct-acting antivirals | 10.1016/j.ijid.2021.12.320 | 2022 |
| Noninvasive predictors of esophageal varices in patients with hepatosplenic schistosomiasis mansoni | 10.1016/j.actatropica.2021.106283 | 2022 |
| Staging Fibrosis in Chronic Viral Hepatitis | 10.3390/v14040660 | 2022 |
| Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring | 10.3748/wjg.v28.i25.2890 | 2022 |
| Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis | 10.1007/s10620-021-07122-y | 2022 |
| Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population | 10.1016/j.aohep.2021.100546 | 2022 |
| Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study | 10.3389/fphar.2021.818089 | 2022 |
| Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease | 10.1007/s10620-021-07363-x | 2022 |
| National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents | 10.1016/j.bjid.2022.102388 | 2022 |
| Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study | 10.1016/j.bjid.2022.102697 | 2022 |
| Results of interferon-free treatment for HCV-infected patients with decompensated cirrhosis from a Brazilian real-life cohort | 10.1097/md.0000000000030097 | 2022 |
| Liver Growth and Portal Hypertension Improvement After Percutaneous Recanalization of Chronic Portal Vein Thrombosis in Non-Cirrhotic Participants | 10.1007/s00270-022-03065-7 | 2022 |
| Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis | 10.1016/S2468-1253(20)30357-5 | 2021 |
| BRAZILIAN SOCIETY OF HEPATOLOGY AND BRAZILIAN COLLEGE OF RADIOLOGY PRACTICE GUIDANCE FOR THE USE OF ELASTOGRAPHY IN LIVER DISEASES | 10.1016/j.aohep.2021.100341 | 2021 |
| Aminotransferase-to-platelet ratio index and Fibrosis-4 index score predict hepatic fibrosis evaluated by transient hepatic elastography in hepatitis C virus-infected hemodialysis patients | 10.1097/meg.0000000000002031 | 2021 |
| Applicability of oral fluid samples for tracking hepatitis B virus mutations, genotyping, and phylogenetic analysis | 10.1007/s00705-021-05122-x | 2021 |
| Current management of NAFLD/NASH | 10.1111/liv.14869 | 2021 |
| Association of Polymorphisms in the Glutathione S-Transferase Theta-1 Gene with Cirrhosis and Hepatocellular Carcinoma in Brazilian Patients with Chronic Hepatitis C | 10.3390/vaccines9080831 | 2021 |
| Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study | 10.1186/s12933-021-01388-2 | 2021 |
| Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis | 10.1016/j.aohep.2019.05.011 | 2020 |
| The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort | 10.1097/MEG.0000000000001496 | 2020 |
| Reply to Drs Mantovani and Zusi | 10.1016/j.numecd.2019.09.010 | 2020 |
| New drugs for non¿alcoholic steatohepatitis | 10.1111/liv.14354 | 2020 |
| Circulating microRNAs associated with liver fibrosis in chronic hepatitis C patients | 10.1016/j.bbrep.2020.100814 | 2020 |
| 2-D shear wave elastography for the evaluation of liver fibrosis in hepatosplenic schistosomiasis: reliability of a single measurement and interhepatic lobe variability | 10.4269/ajtmh.20-0032 | 2020 |
| Survival Tree Score: A Novel Approach to predict mortality in cirrhotic patients | 2020 | |
| Transient Hepatic Elastography Has the Best Performance to Evaluate Liver Fibrosis in Non-alcoholic Fatty Liver Disease (NAFLD) | 10.1016/j.aohep.2018.09.003 | 2019 |
| Organ dysfunction in cirrhosis | 10.1097/meg.0000000000001366 | 2019 |
| How are HCV-infected patients being identified in Brazil: a multicenter study | 10.1016/j.bjid.2019.01.006 | 2019 |
| Efficacy of Diacerein in Reducing Liver Steatosis and Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: a Randomized, Placebo-Controlled Trial. | 10.1111/dom.13643 | 2019 |
| PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: a prognostic marker beyond liver disease? | 10.1016/j.numecd.2019.06.002 | 2019 |
| Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil | 10.1016/j.aohep.2019.08.001 | 2019 |
| Detection of occult hepatitis B in serum and oral fluid samples | 10.1590/0074-02760170071 | 2018 |
| Abbreviated mpMRI protocol for diffuse liver disease: a practical approach for evaluation and follow-up of NAFLD | 10.1007/s00261-018-1504-5 | 2018 |
| Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients | 10.1097/md.0000000000009881 | 2018 |
| Usefulness of in-house real time PCR for HBV DNA quantification in serum and oral fluid samples | 10.1016/j.jviromet.2018.03.001 | 2018 |
| Hepatitis C Virus-Infected Responders and Relapsers to Treatment Show Similar Genetic Profiles of IL28B and IL10 Single Nucleotide Polymorphisms | 10.1155/2018/2931486 | 2018 |
| Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with Controlled Attenuation Parameter (CAP) | 10.1111/jvh.12930 | 2018 |
| Lower levels of dehydroepiandrosterone sulfate are associated with more advanced liver fibrosis in chronic hepatitis C | 10.1111/jvh.12812 | 2018 |
| The Anti-inflammatory Role of Propranolol in Cirrhosis: Preventing the Inflammatory Exhaustion? | 10.1016/j.jhep.2016.08.007 | 2017 |
| Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C | 10.4254/wjh.v9.i6.310 | 2017 |
| Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis | 10.1097/meg.0000000000000853 | 2017 |
| Performance of anti-HCV testing in dried blood spots and saliva according to HIV status | 10.1002/jmv.24777 | 2017 |
| Lack of Association between Hepatitis C Virus core Gene Variation 70/91aa and Insulin Resistance | 10.3390/ijms18071444 | 2017 |
| Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study | 10.6061/clinics/2017(06)08 | 2017 |
| Comparison of oral fluid collection methods for the molecular detection of hepatitis B virus | 10.1111/odi.12692 | 2017 |
| Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study | 10.5604/01.3001.0010.5280 | 2017 |
| Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients | 10.1016/j.virusres.2017.09.022 | 2017 |
| High prevalence of insulin resistance among Brazilian chronic hepatitis C patients | 10.1590/2359-3997000000315 | 2017 |
| Reply to contribution on the topic of hypovitaminosis D in chronic hepatitis C | 2016 | |
| 'The correlation between obesity-related diseases and non-alcoholic fatty liver disease in women in the pre-operative evaluation for bariatric surgery assessed by transient hepatic elastography' | 10.1007/s11695-016-2054-y | 2016 |
| Propranolol improves endothelial dysfunction in advanced cirrhosis: the `endothelial exhaustion? hypothesis | 10.1136/gutjnl-2016-311696 | 2016 |
| RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients | 10.1371/journal.pone.0153796 | 2016 |
| NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? | 10.3390/ijms17040460 | 2016 |
| Evaluation of dried blood spot samples for hepatitis C virus detection and quantification | 10.1016/j.jcv.2016.07.009 | 2016 |
| No correspondence between resistance mutations in the HCV-NS3 protease at baseline and early telaprevir-based triple therapy | 10.1016/j.bbacli.2015.01.004 | 2015 |
| Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients. | 2015 | |
| Inosine triphosphatase allele frequency and association with ribavirin-induced anaemia in Brazilian patients receiving antiviral therapy for chronic hepatitis C. | 10.1590/0074-02760150104 | 2015 |
| Intermediate fibrosis staging in hepatitis C: a problem not overcome by optimal samples or pathologists' expertise. | 2015 | |
| Increasing Aortic Stiffness is Predictive of Advanced Liver Fibrosis in Patients with Type 2 Diabetes: the Rio-T2DM Cohort Study | 10.1111/liv.12994 | 2015 |
| Cutaneous Eruption due to Telaprevir | 10.1159/000439264 | 2015 |
| Peginterferon plus ribavirin and sustained virological response rate in HCV-related advanced fibrosis: a real life study | 10.1016/j.bjid.2013.05.007 | 2014 |
| Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma | 10.1002/jmv.23837 | 2014 |
| Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations | 10.1016/j.jcv.2014.04.001 | 2014 |
| on-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment | 2014 | |
| Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study | 10.1186/1743-422x-10-57 | 2013 |
| Importance of Collection Methods and Stability of Oral Fluid Samples for Hepatitis B Surface Antigen Detection | 10.1002/jcla.21582 | 2013 |
| Simultaneous detection of hepatitis c virus antigen and antibodies in dried blood spots | 10.1016/j.jcv.2013.02.014 | 2013 |
| Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis | 10.1111/j.1872-034X.2012.01106.x | 2013 |
| Prevalence of occult hepatitis B virus infection in kidney transplant recipients. | 2013 | |
| Interleukin 28B-related polymorphisms: A pathway for understanding hepatitis C virus infection? | 2013 | |
| Acute Kidney Injury Network Criteria as a Predictor of Hospital Mortality in Cirrhotic Patients With Ascites | 10.1097/MCG.0b013e31822e8e12 | 2012 |
| An evaluation of different saliva collection methods for detection of antibodies against hepatitis C virus (anti-HCV). | 10.1111/j.1600-0714.2012.01176.x | 2012 |
| Hepatitis B virus genotypes in Southeast Brazil and its relationship with histological features | 10.1590/S0074-02762012000600013 | 2012 |
| Dried blood spot samples: Optimization of commercial EIAs for hepatitis C antibody detection and stability under different storage conditions. | 10.1002/jmv.23379 | 2012 |
| A single nucleotide polymorphism, rs129679860, in the IL28B locus is associated with the viral kinetics and a sustained virological response in a chronic, monoinfected hepatitis C virus genotype-1 Brazilian population treated with pegylated interferon-ribavirin | 10.1590/S0074-02762012000700008 | 2012 |
| Association of IL-10, IL-4, and IL-28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro | 10.1186/1756-0500-5-508 | 2012 |
| Identification of novel recombinants of hepatitis B virus genotypes F and G in human immunodeficiency virus-positive patients from Argentina and Brazil | 10.1099/vir.0.047324-0 | 2012 |
| Evaluation of saliva specimens as an alternative sampling method to detect hepatitis B surface antigen | 10.1002/jcla.20447 | 2011 |
| Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. | 10.1111/j.1478-3231.2011.02482.x. | 2011 |
| Risk factors for long term mortality in a large cohort of waitlisted patients for liver transplantation in brazil | 10.1002/lt.22344 | 2011 |
| Central Venous Saturation: a prognostic tool in cardiac surgery patients | 10.1177/0885066609355398 | 2010 |
| Predictors of response to viral chronic hepatitis C treatment | 2010 | |
| Agresive inflamatory myifibroblastic tumor of the liver with underlying schistosomiasis: a casa report | 2010 | |
| Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. | 2009 | |
| Is the rapid virologic response a positive predictive factor of sustained virologic response in all pretreatment status genotype 1 hepatitis c patients treated with peginterferon-alpha2b and ribavirin? | 2009 | |
| HBV-DNA Levels in HBsAg-positive Blood Donors and its Relationship With Liver Histology. | 2007 | |
| Orthotopic Liver Transplantation in Glucose-6-phosphatase Deficiency - von Gierke Disease - with Multiple Hepatic Adenomas and Concomitant Focal Nodular Hyperplasia | 2007 | |
| Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function. | 2007 | |
| Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates. | 2007 | |
| Analysis of morphological variables and arterialization in the differential diagnosis of hepatic nodules in explanted cirrhotic livers. | 2007 | |
| Gamma-Glutamyl Transferase (GGT) as an Independent Predictive Factor of Sustained Virologic Response in Patients With Hepatitis C Treated With Interferon-Alpha and Ribavirin. | 2005 | |
| Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers | 2005 | |
| Hepatitis B virus-infected HBeAg-negative blood donors, biochemical, virological and histological profile | 2004 | |
| Comparative study of the prevalence of thyroid disfunction induced by intereron alpha 2b and pegylated interferon alpha -2b in patients with chronic hepatitis C | 2004 | |
| Prevalence of thyroid dysfunction induced by pegylated interferon in patients with chronic hepatitis C | 2004 | |
| HCV-RNA results at the 12th week as a predictive factor of sustained virological response in chronic hepatitis c patients with detectable viremia in the 4th week of treatment with alpha interferon and ribavirin | 2004 | |
| Haematological abnormalities during treatment of chronic hepatitis C with pegylated interferon alpha 2b (PEG-IFN) and ribavirin (RBV) | 2004 | |
| HCV-RNA na 12a semana como fator preditivo de resposta virológica sustentada em portadores de hepatitie C com viremia detectável na 4a semana de tratamento com interferon (IFN) convencional e ribavirina | 2003 | |
| Estudo comparativo da eficácia do tratamento da hepatite crônica C com dois tipos de interferon alfa (IFN-alfa):IFN-alfa 2B X IFN-alfa-similar | 2003 | |
| Relação entre a carga viral do VHB e histologia hepática em doadores de sangue AgHBs positivo | 2003 | |
| Fatores associados com sinais ultra-sonográficos de doença hepática avançada na doença hepática gordurosa não alcoólica (DHGNA) | 2003 | |
| Evolução e causas de mortalidade no pós-transplante (TX) hepático | 2003 | |
| Prevalência do anticorpo contra o vírus da hepatite A (anti-VHA) em portadores de doença hepática:estudo comparativo entre pacientes de hospital público e de clínica particular | 2003 | |
| Resposta virológica na 4a semana em portadores de hepatite C virgens de tratamento:estudo comparativo entre tratamento com interferon padrão vs peguilado | 2003 | |
| Interferon peguilado (PEG-IFN) e ribavirina (RBV) em portadores de hepatite C virgens de tratamento:resposta virológica na 4a semana | 2003 | |
| Correlação entre índice de atividade inflamatória e estadiamento em doadores de sangue AgHBs positivo | 2003 | |
| Estudo comparativo entre doadores de sangue AgHBe positivo e negativo | 2003 | |
| Estudo comparativo da prevalência de alterações tiroidianas induzidas pelo interferon alfa 2B e PEG-interferon alfa-2B em pacientes portadores de infecção pelo vírus da hepatite C | 2003 | |
| HCV-RNA na 4a semana como fator preditivo de resposta virológica sustentada em portadoresd de hepatite c tratados com interferon (IFN) convencional e ribavirina | 2003 | |
| Prevalência de alterações tireoidianas induzidas pelo interferon peguilado em pacientes com infecção pelo vírus da hepatite C | 2003 | |
| Perfil bioquímico, virológico e histológico do doadore de sangue com infecção pelo vírus B, AgHBe negativo | 2003 | |
| Tratamento da hepatite crônica c com interferon alfa (IFN-alfa) e ribavirina (RBV) - valor do estágio da doença, genótipo e gama-glutamiltransferase (GGT) | 2003 | |
| Características Clínicas e laboratoriais de226 pacientes com esteatose hepática à ultra-sonografia (US) | 2003 | |
| Caracterísiticas clínicas e laboratoriais de 226 pacientes com esteatose hepática à ultra-sonografia (US) | 2003 | |
| Fatores associados à elevação de alfa-feto proteína no carcinoma hepatocelular | 2003 | |
| Caracterísitcas epidemiológicas e clínicas de 98 casos de carcinoma hepatocelular | 2003 | |
| Características clínicas, laboratoriais e histológicas de 41 casos de cirrose biliar primária (CBP) | 2003 | |
| Hepatitis B virus viremia profile in HBsAg positive blood donors in Rio de Janeiro, Brazil | 2003 | |
| Hepatitis C virus transfusion-transmitted infection in brazilian cardiac surgery patients | 2002 | |
| Relationship between gamma glutamyl transpeptidase (GGT) levels and treatment response in chronic hepaitis C | 2002 | |
| The incidence of GB virus C / Hepatitis G virus infection in brazilian patients who received blood transfusion during cardiac surgery | 2001 | |
| Lack of detection of HHV-8 infection in transfused brazilian patients | 2000 |
Eventos:
(0.00% eventos com DOI)